
Acadia Healthcare (ACHC) Stock Forecast & Price Target
Acadia Healthcare (ACHC) Analyst Ratings
Bulls say
Acadia Healthcare Co is poised for continued growth and we expect this trend to continue both organically and through strategic acquisitions. They have demonstrated strong demand in the behavioral health sector and have implemented measures to ensure the safety of their patients, employees and communities during the pandemic. Although they face some risks, we believe the company's focus on operational improvement and capital discipline justifies a premium valuation, leading us to maintain our buy rating and increase our target price to $31.
Bears say
Acadia Healthcare Co is facing several fundamental challenges that are likely to have a negative impact on its stock. These include soft CTC growth, specialty revenue decline, ongoing payor denials and reorganization efforts, which could lead to higher costs and lower profitability. Additionally, there are risks associated with potential government investigations and exposure to vulnerable patients. Despite some positive aspects, such as strong same-facility admissions and a diversified payor mix, it is difficult to have confidence in the company's stability based on current market trends.
This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction
Start investing in Acadia Healthcare (ACHC)
Order type
Buy in
Order amount
Est. shares
0 shares